{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:37:32Z","timestamp":1789238252864,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.yebeh.2022.108633","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T07:09:15Z","timestamp":1647500955000},"page":"108633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Pseudoresistance in idiopathic\/genetic generalized epilepsies \u2013 Definitions, risk factors, and outcome"],"prefix":"10.1016","volume":"130","author":[{"given":"Joanna","family":"Gesche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Dyremose","family":"Cornwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Delcomyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Rubboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yebeh.2022.108633_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yebeh.2013.06.019","article-title":"Uncontrolled epilepsy is not necessarily the same as drug-resistant epilepsy: differences between populations with newly diagnosed epilepsy and chronic epilepsy","volume":"29","author":"Hao","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108633_b0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.seizure.2013.01.010","article-title":"Reasons for uncontrolled seizures in adults; the impact of pseudointractability","volume":"22","author":"Asadi-Pooya","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108633_b0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2019.05.021","article-title":"Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy","volume":"98","author":"Johannessen Landmark","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108633_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.70.2.240","article-title":"Clinical factors of drug resistance in juvenile myoclonic epilepsy","author":"Gelisse","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108633_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain and Development"},{"key":"10.1016\/j.yebeh.2022.108633_b0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.0013-9580.2004.19704.x","article-title":"Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies","volume":"45","author":"Gelisse","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108633_b0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108633_b0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yebeh.2016.10.040","article-title":"Photosensitivity in generalized epilepsies","volume":"68","author":"Poleon","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108633_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eplepsyres.2018.04.007","article-title":"The seizure precipitating effect of alcohol: a prospective observational cross-over study","volume":"143","author":"Samsonsen","year":"2018","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.yebeh.2022.108633_b0050","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1046\/j.1528-1157.2001.19301.x","article-title":"Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy","volume":"42","author":"Gordon","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108633_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.02.001","article-title":"Treatment non-adherence in pseudo-refractory epilepsy","volume":"122","author":"Brodtkorb","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2022.108633_b0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0404.1985.tb00900.x","article-title":"Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy)","volume":"72","author":"Janz","year":"1985","journal-title":"Acta Neurol Scandinavica"},{"key":"10.1016\/j.yebeh.2022.108633_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00499","article-title":"Electroencephalography in the diagnosis of genetic generalized epilepsy syndromes","volume":"8","author":"Seneviratne","year":"2017","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108633_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41582-021-00583-9","article-title":"Genetic generalized epilepsies in adults \u2014 challenging assumptions and dogmas","volume":"18","author":"Vorderw\u00fclbecke","year":"2022","journal-title":"Nature Rev Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108633_b0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/acn3.51255","article-title":"Trait impulsivity in Juvenile Myoclonic Epilepsy","volume":"8","author":"Shakeshaft","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108633_b0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.yebeh.2011.03.036","article-title":"Personality traits in patients with juvenile myoclonic epilepsy","volume":"21","author":"Moschetta","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108633_b0085","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/epi.16870","article-title":"Social outcome and psychiatric comorbidity of generalized epilepsies \u2013 a case-control study","volume":"62","author":"Gesche","year":"2021","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108633_b0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ene.14142","article-title":"Epidemiology and outcome of idiopathic generalized epilepsy in adults","volume":"27","author":"Gesche","year":"2020","journal-title":"Eur J Neurol"},{"issue":"18","key":"10.1016\/j.yebeh.2022.108633_b0095","doi-asserted-by":"crossref","first-page":"e2519","DOI":"10.1212\/WNL.0000000000010644","article-title":"Patterns and prognostic markers for treatment response in generalized epilepsies","volume":"95","author":"Gesche","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108633_b0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1037\/a0030550","article-title":"New tricks for an old measure: the development of the Barratt Impulsiveness Scale-Brief (BIS-Brief)","volume":"25","author":"Steinberg","year":"2013","journal-title":"Psychol Assess"},{"issue":"Issue 22, Part 2","key":"10.1016\/j.yebeh.2022.108633_b0105","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/01.wnl.0000313148.34629.1d","article-title":"Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy","volume":"70","author":"Baykan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108633_b0110","first-page":"818","article-title":"Is pseudo-intractability in population of patients with epilepsy still alive in the 21st century? Audit of 100 seizure-free patients, referred with the diagnosis of pharmacoresistant epilepsy","volume":"31","author":"Bajacek","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.yebeh.2022.108633_b0115","first-page":"284","article-title":"Pseudo-refractory epilepsy","volume":"18","author":"Kutlu","year":"2013","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.yebeh.2022.108633_b0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0035-3787(04)71182-0","article-title":"D\u00e9finition de la pharmaco-r\u00e9sistance : le point de vue de l\u2019\u00e9pileptologue","volume":"160","author":"Genton","year":"2004","journal-title":"Revue Neurologique"},{"issue":"11","key":"10.1016\/j.yebeh.2022.108633_b0125","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/14737175.2021.1931126","article-title":"Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy","volume":"21","author":"Ascoli","year":"2021","journal-title":"Expert Rev Neurother"},{"issue":"1-2","key":"10.1016\/j.yebeh.2022.108633_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000479003","article-title":"Drug-level monitoring on admission for presurgical epilepsy evaluation","volume":"78","author":"Constantinescu","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.yebeh.2022.108633_b0135","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4045\/tidsskr.11.1149","article-title":"Epilepsikirurgi \u2013 utredning og pasientseleksjion","volume":"14","author":"Nakken","year":"2012","journal-title":"Tidsskr Nor Legeforen"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108633_b0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/biomedicines9050470","article-title":"Pharmacological and therapeutic approaches in the treatment of epilepsy","volume":"9","author":"Ghosh","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108633_b0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00023210-199810030-00002","article-title":"Pharmacoresistance in epilepsy \u2013 how should it be defined?","volume":"10","author":"Perucca","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2022.108633_b0150","first-page":"284","article-title":"Pseudo-refractory epilepsy","volume":"18","author":"Kutlu","year":"2013","journal-title":"Neurosciences"},{"key":"10.1016\/j.yebeh.2022.108633_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00461","article-title":"Psychogenic non-epileptic seizures and pseudo-refractory epilepsy, a management challenge","volume":"11","author":"Anzellotti","year":"2020","journal-title":"Front Neurol"},{"issue":"11-12","key":"10.1016\/j.yebeh.2022.108633_b0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2298\/MPNS1412372J","article-title":"Terminal remission is possible in some patients with juvenile myoclonic epilepsy without therapy","volume":"67","author":"Jovic","year":"2014","journal-title":"Med Pregl"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:46:45Z","timestamp":1761504405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"alternative-id":["S1525505022000828"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108633","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudoresistance in idiopathic\/genetic generalized epilepsies \u2013 Definitions, risk factors, and outcome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108633"}}